insulinoma tumour pancreas derived beta cells secretes insulin rare form neuroendocrine tumour insulinomas benign grow exclusively origin within pancreas minority metastasize insulinomas one functional pancreatic neuroendocrine tumour pnet group functional increases production medical subject headings classification insulinoma subtype islet cell beta cells secrete insulin response increases blood glucose resulting increase insulin acts lower blood glucose back normal levels point secretion insulin stopped contrast secretion insulin insulinomas rather independent blood glucose tumours continue secrete insulin causing blood glucose levels fall result patients present symptoms low blood glucose hypoglycemia improved eating diagnosis insulinoma usually made biochemically low blood glucose elevated insulin proinsulin cpeptide levels confirmed localizing tumour medical imaging angiography definitive treatment patients insulinomas usually develop neuroglycopenic symptoms include recurrent headache lethargy diplopia blurred vision particularly exercise fasting severe hypoglycemia may result seizures coma permanent neurological damage symptoms resulting catecholaminergic response hypoglycemia ie tremulousness palpitations tachycardia sweating hunger anxiety nausea common sudden weight gain sometimes seencitation needed diagnosis insulinoma suspected patient symptomatic fasting hypoglycemia conditions whipple triad need met diagnosis true hypoglycemia blood tests needed diagnose available proinsulin level might useful well blood tests may help rule conditions cause hypoglycemia normally endogenous insulin production suppressed setting hypoglycemia fast usually supervised hospital setting done see insulin levels fail suppress strong indicator presence insulinsecreting tumourcitation needed test patient may caloriefree caffeinefree liquids capillary blood glucose measured every hours using reflectance meter values mgdl mmoll obtained frequency blood glucose measurement increased every hour values mgdl mmoll point patient symptoms hypoglycemia blood test drawn serum glucose insulin proinsulin cpeptide levels fast stopped point hypoglycemia treated intravenous dextrose carbohydratecontaining food drinkcitation needed insulinoma might localized noninvasive means using ultrasound ct scan mri techniques pentetreotide scan sensitive ultrasound ct mri detection somatostatin receptor positive tumours good diagnostic tool insulinomas endoscopic ultrasound sensitivity depending location tumour detecting sometimes angiography percutaneous transhepatic pancreatic vein catheterization sample blood insulin levels required calcium injected selected arteries stimulate insulin release various parts pancreas measured sampling blood respective veins use calcium stimulation improves specificity testduring surgery remove insulinoma intraoperative ultrasound sometimes localize tumour helps guide surgeon operation higher sensitivity noninvasive imaging testscitation needed definitive management surgical removal insulinoma may involve removing part pancreas well whipple procedure distal pancreatectomy medications diazoxide somatostatin used block release insulin patients surgical candidates otherwise inoperable tumours streptozotocin used islet cell carcinomas produce excessive insulin combination chemotherapy used either doxorubicin streptozotocin fluorouracil streptozocin patients doxorubicin contraindicated metastasizing tumours intrahepatic growth hepatic arterial occlusion embolization usedcitation needed patients benign insulinomas cured surgery persistent recurrent hypoglycemia surgery tends occur patients multiple tumours patients develop diabetes mellitus surgerycitation needed insulinomas rare neuroendocrine tumours incidence estimated one four new cases per million persons per year insulinoma one common types tumours arising islets langerhans cells pancreatic endocrine tumours estimates malignancy metastases range insulinomas originate pancreas rare cases ectopic pancreatic tissue cases associated tumours parathyroid glands pituitary multiple endocrine neoplasia type likely multiple malignant insulinomas small less cmcitation needed hypoglycemia first recognized century discovery insulin use treatment diabetics hyperinsulinism suspected cause hypoglycemia nondiabetics pioneering description hyperinsulinism cause hypoglycemia published seale harris first report surgical cure hypoglycemia removing islet cell tumour needed insulinoma removed woman munich provided insulin mrna used first human gene cloning experiment axel ulrich cloned gene e coli therapeutic insulin used today derives womans pancreatic insulinoma pancreatic insulinoma chromogranin insulin immunostain httpsenwikipediaorgwikiinsulinoma